Tag: Emcure Pharma

Speaking at the 76th session of the UN General Assembly last month, Prime Minister Narendra Modi said: “India has developed the world’s first DNA vaccine. An m-RNA vaccine is in the... Read More

Emcure Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra. Emcure's product portfolio includes tablets, capsules (both Softgel capsules and hard-gel capsules) and injectables. Emcure is planning to raise... Read More

Gennova Biopharmaceuticals' COVID-19 vaccine has been found to be safe and effective in an early-stage study, according to India's drug regulator. The company has been allowed to conduct further studies to... Read More

Emcure is growing pharma company with good future projects and provides overall opportunities for both professional and personal development. Strong growth in generic business,oncology and domestic business is strong. Pros Good working culture,... Read More

Pune-based Gennova Biopharmaceuticals has revealed that its mRNA vaccine for COVID-19 is being continuously peer reviewed and is optimistic of launching it before the end of this year. Gennova's HGCO19 is... Read More

An m-RNA vaccine is in the final stages of development.” The announcement in the lofty halls of the UNGA in New York refers to a 15-year-old Pune-based pharmaceutical company, Gennova... Read More

From starting with being a number cruncher to working towards bettering women's health, and somewhere in between mentoring 11 to 18-year-olds towards being problem solvers, she does it all with... Read More

India’s first mRNA-based Covid-19 vaccine, from Gennova Biopharma, a subsidiary of Pune-based Emcure Pharmaceuticals, is in its final stages. Soumya Swaminathan, chief scientist at the World Health Organization (WHO), visited... Read More

Gennova Biopharmaceuticals’ Covid-19 jab HGCO19, based on the mRNA technology platform, will be a lyophilized vaccine or one that is based on freeze-drying. This should help store the vaccine at... Read More

Clinical trials of the two Indian vaccine candidates—the mRNA jab from Gennova and the Receptor Binding Protein (RBD) vaccine by Biological E—are expected to speed up after the government agreed... Read More